Price Targets | Analyst valuations range from $85 to $119, with an average target of $98, reflecting mixed perspectives on JCI's ability to achieve best-in-class margins without portfolio optimization. |
Leadership Transition | Under CEO Joakim Weidemanis, Johnson Controls is pursuing incremental yet effective strategic changes focused on operational excellence and enhanced customer relationships. |
Margin Potential | Explore how JCI's LEAN execution initiatives and strategic review process could drive significant margin improvement despite challenges in the Fire & Security segment. |
Record Backlog | Johnson Controls' impressive $14 billion backlog, up 12% year-over-year, provides exceptional revenue visibility and demonstrates strong market demand for its building technologies. |

Metrics to compare | JCI | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipJCIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 46.4x | 36.3x | 12.7x | |
PEG Ratio | 0.45 | 0.81 | 0.03 | |
Price / Book | 6.7x | 6.2x | 1.4x | |
Price / LTM Sales | 3.7x | 2.6x | 1.3x | |
Upside (Analyst Target) | 2.0% | 6.4% | 20.0% | |
Fair Value Upside | Unlock | −6.5% | 5.6% | Unlock |
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on building the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It also develops the Optejet User Filled Device for horizontal, microdose spray delivery of ophthalmic liquids, such as artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Laguna Hills, California.